US Stock MarketDetailed Quotes

NRBO NeuroBo Pharmaceuticals

Watchlist
  • 2.5300
  • -0.1400-5.24%
Close Nov 4 16:00 ET
  • 2.6200
  • +0.0900+3.56%
Post 16:54 ET
21.47MMarket Cap-507P/E (TTM)

NeuroBo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroBo Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

NeuroBo Pharmaceuticals Earnings Reports

  • NeuroBo Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 15 05:11

  • NeuroBo Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 21:02

  • NeuroBo Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 29 10:26

  • NeuroBo Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 05:29

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data